Publications by authors named "M Moorhouse"
Article Synopsis
- This text discusses the importance of addressing health inequities among minority populations within public health, emphasizing the integration of Critical Race Theory (CRT) for achieving health equity.
- The study examined academic syllabi from accredited Master of Public Health (MPH) programs to assess how well they align with the Public Health Critical Race (PHCR) Praxis.
- Key findings included themes such as Structural Determinism, Intersectionality, and the emergence of new themes like Antiracism Practices, highlighting the significant connection between public health education and critical race studies.
Article Synopsis
- * Methods: Over 48 weeks, 101 Black women (median age 35) were transitioned to the new regimen, and the study assessed retention rates, viral suppression, weight changes, and lipid panel improvements.
- * Results: Retention was high (92%), with over 90% maintaining viral suppression. Participants experienced an average weight gain of 2.7 kg and significant improvements in cholesterol and triglyceride
Background: ADVANCE compared 3 World Health Organization-recommended first-line regimens in participants with HIV who were antiretroviral naive.
Methods: This randomized, open-label, noninferiority trial enrolled participants living with HIV with no antiretroviral exposure in the previous 6 months to 1 of the following arms: tenofovir alafenamide (TAF) / emtricitabine (FTC) + dolutegravir (DTG) (2 tablets), tenofovir disoproxil fumarate (TDF) / FTC + DTG (2 tablets), or a fixed-dose combination of TDF / FTC / efavirenz (EFV) (1 tablet). We report the final safety and efficacy data up to 192 weeks.
Aims: Dolutegravir increases serum creatinine by inhibiting its renal tubular secretion and elimination. We investigated determinants of early changes in serum creatinine in a southern African cohort starting first-line dolutegravir-based antiretroviral therapy (ART).
Methods: We conducted a secondary analysis of data from participants in a randomized controlled trial of dolutegravir, emtricitabine and tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide fumarate (TAF) (ADVANCE, NCT03122262).
Introduction: Public health has declared a commitment toward diversity as a whole, with a commitment toward addressing and dismantling racism being at the forefront. Although public health has admirably taken on this mission, and the foundational principles of public health align with social justice and health equity, public health as a discipline is vastly behind other fields in integrating and utilizing critical race theorizations. Of particular concern is the lack of critical race theorization within public health education materials.
View Article and Find Full Text PDF